Analysts have been eager to weigh in on the Healthcare sector with new ratings on Generation Bio (GBIO – Research Report), RegenXBio (RGNX – Research Report) and Halozyme (HALO – Research Report).
Generation Bio (GBIO)
In a report issued on January 17, Eun Yang from Jefferies maintained a Buy rating on Generation Bio, with a price target of $5.00. The company’s shares closed last Monday at $1.74, close to its 52-week low of $0.86.
According to TipRanks.com, Yang is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Generation Bio with a $9.25 average price target.
See the top stocks recommended by analysts >>
RegenXBio (RGNX)
In a report issued on January 17, Mani Foroohar from Leerink Partners maintained a Hold rating on RegenXBio. The company’s shares closed last Monday at $13.98, close to its 52-week low of $12.76.
According to TipRanks.com, Foroohar has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on RegenXBio is a Moderate Buy with an average price target of $31.33, representing a 129.0% upside. In a report issued on January 17, Wedbush also reiterated a Hold rating on the stock with a $21.00 price target.
Halozyme (HALO)
In a report issued on January 17, David Risinger from Leerink Partners maintained a Hold rating on Halozyme, with a price target of $37.00. The company’s shares closed last Monday at $33.94.
According to TipRanks.com, Risinger is a 5-star analyst with an average return of
Currently, the analyst consensus on Halozyme is a Moderate Buy with an average price target of $48.00, implying a 40.1% upside from current levels. In a report issued on January 17, Goldman Sachs also maintained a Hold rating on the stock with a $40.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GBIO:
